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Key questions
What is already known?
 ► The One Health movement is currently experiencing 
a rise in political and financial attention.
 ► There are well-documented barriers to collaboration 
between human, animal and environmental health 
specialists.
What are the new findings?
 ► Recent attention to One Health has increased power 
struggles and coordination challenges.
 ► Stakeholders are shifting operationalisation in direc-
tions most aligned with their own interests, thereby 
splintering the movement.
What do the new findings imply?
 ► The increase in organisations conducting diverse 
activities under the One Heath umbrella presents an 
opportunity to strengthen the evidence base to pro-
vide clearer guidance on priority areas.
AbsTrACT
Introduction The global health field has witnessed the 
rise, short-term persistence and fall of several movements. 
One Health, which addresses links between human, animal 
and environmental health, is currently experiencing a 
surge in political and financial attention, but there are well-
documented barriers to collaboration between stakeholders 
from different sectors. We examined how stakeholder 
dynamics and approaches to operationalising One Health 
have evolved further to recent political and financial support 
for One Health.
Methods We conducted a mixed methods study, first by 
qualitatively investigating views of 25 major policymakers 
and funders of One Health programmes about factors 
supporting or impeding systemic changes to strengthen the 
One Health movement. We then triangulated these findings 
with a quantitative analysis of the current operations of 100 
global One Health Networks.
results We found that recent attention to One Health at 
high-level political fora has increased power struggles 
between dominant human and animal health stakeholders, 
in a context where investment in collaboration building skills 
is lacking. The injection of funding to support One Health 
initiatives has been accompanied by a rise in organisations 
conducting diverse activities under the One Health umbrella, 
with stakeholders shifting operationalisation in directions 
most aligned with their own interests, thereby splintering 
and weakening the movement. While international attention 
to antimicrobial resistance was identified as a unique 
opportunity to strengthen the One Health movement, there 
is a risk that this will further drive a siloed, disease-specific 
approach and that structural changes required for wider 
collaboration will be neglected.
Conclusion Our analysis indicated several opportunities 
to capitalise on the current growth in One Health initiatives 
and funding. In particular, evidence from better monitoring 
and evaluation of ongoing activities could support the case 
for future funding and allow development of more precise 
guidelines on best practices.
InTroduCTIon
The inextricable connections between 
human health, animal health and the state of 
the environment are in the spotlight vis-à-vis 
global health policymakers.1–4 For example, it 
has been estimated that 75% of all emerging 
diseases affecting humans originate from an 
animal source, causing 2.7 million deaths 
annually.5 Even more premature mortality, 
in excess of three million annual deaths, is 
attributed to outdoor air pollution, which is 
substantially driven by intensive livestock and 
crop production.6 7 Although the concept 
of integrating efforts to address health chal-
lenges that emerge at the human-animal-eco-
system interface is not new,8 a number of 
related movements have gained traction 
among health policymakers and funders 
over the past 15 years, including One 
Health, EcoHealth and Planetary Health. 
While these approaches are underpinned by 
differing values and assumptions,9 10 they all 
broadly rally around a shared notion based 
on ‘…the collaborative effort of multiple 
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box 1 summary of information about the Tripartite
 ► In 2010, the FAO, OIE and WHO expressed their collective commit-
ment to strengthening international collaboration and coordination 
of efforts in response to global health risks at the human-ani-
mal-ecosystem interface. This commitment was captured in a 
Tripartite Concept Note.
 ► In 2017, the Tripartite reaffirmed its commitment and leadership 
role in applying the principles of One Health to address global is-
sues. Focus areas and scope of activities for the 2017 to 2020 pe-
riod were defined as: antimicrobial resistance; food safety; early 
warning and surveillance/monitoring system; preparedness and 
response to emerging, re-emerging and neglected infectious dis-
eases; and coordinated research and development.
 ► In May 2018, the Tripartite formalised their agreement in a 
Memorandum of Understanding, which provides a framework to 
further the FAO, OIE and WHO’s ‘…shared goals and objectives 
in regard to the development and implementation of multi-sec-
toral approaches’.17 It is reported that the Tripartite group is pre-
paring a work plan and will be holding annual Tripartite Executive 
Coordination Meetings.
disciplines—working locally, nationally and globally—to 
attain optimal health for people, animals, and our envi-
ronment’.11
As this overarching aim suggests, the envisaged multidis-
ciplinary approach relies on systemic changes to establish 
a more cross-cutting approach to research, surveillance 
and responses to global health challenges, breaking away 
from a disease-specific or siloed mode of operation.12–14 
‘One Health’, in particular, has received significant polit-
ical attention and support, including being formally 
endorsed by a number of multilateral institutions, such 
as the World Health Organization (WHO), World Orga-
nization for Animal Health (OIE), Food and Agricul-
ture Organization of the United Nations (FAO) and the 
World Bank.15–17 The One Health movement first gained 
this ‘international currency’ after the outbreak of highly 
pathogenic avian influenza (HPAI) in the early 2000s and 
the associated mobilisation of an international response 
jointly led by the FAO, OIE and WHO.10 This response was 
widely regarded as an unprecedented paradigm shift in 
global governance as it marked a commitment for greater 
organisational collaboration and a departure from tradi-
tional siloed modes of working.18 Indeed, Chien argues 
that at the height of the avian influenza crisis, adopting 
an all-inclusive One Health approach served to reduce 
conflict between competing institutional priorities of 
FAO, OIE and WHO, defend legitimacy and facilitate a 
shared commitment for cooperation.18
Since 2010, political and financial attention to One 
Health has surged, with several developments in the last 
3 years. The FAO, OIE and WHO launched a strategy 
for partnership (known as the Tripartite Concept Note) 
in April 2010 at the International Ministerial Confer-
ence on Animal and Pandemic Influenza in Vietnam 
(box 1).16 In recent years, collaboration based on 
One Health principles has been a topic of discussion 
at several high-level political fora, such as at the 2016 
UN General Assembly, the 2015 G7 Health Ministers’ 
Meeting and the 2016 Commonwealth Health Minis-
ters Meeting. The Tripartite released a second strategic 
document in 2017,19 reaffirming its commitment to 
‘more broadly embrace the One Health approach’.20 In 
parallel, there has been substantial investment in One 
Health and a rapid growth in the number of organisa-
tions stating that they are working to enhance collabo-
ration across human, animal and environmental health 
sectors.21–24
While this broader framing of One Health by the 
Tripartite and the recent surge in political and financial 
commitment has encouraged a wide range of organisa-
tions to join the One Health community, it has also meant 
that the One Health concept risks being appropriated by 
a range of different actors to label a range of different 
initiatives (table 1).10 Multiple interpretations of the 
concept have emerged,10 with actors often competing 
for attention and funding for their programmatic prior-
ities.25 Galaz and colleagues identify three dominant 
narratives within the One Health community (the ‘inte-
gration narrative’, ‘risk and surveillance narrative’ and 
‘economic benefit narrative’) that reflect very different 
institutional logics, power structures and agendas.10 26 
These fractions and submovements within One Health 
are also reflected outside of the movement. For instance, 
Lerner and Berg argue that despite their similarities, 
important distinctions exist between EcoHealth, Plane-
tary Health and One Health and that thus far these move-
ments have struggled to work together despite calls27 28 
for their convergence to strengthen collective efforts and 
to avoid duplication.9
Indeed, concern has been raised that the current 
surge in political and financial support for One Health 
is primarily driven by recent zoonotic disease outbreaks 
and crises1 10 and that structural changes to support 
collaboration between the human, animal and environ-
mental health sectors have therefore been limited in 
focus.26 29 30 For example, a study in Nigeria found that 
while crises like HPAI have been instrumental in cata-
lysing intersectoral action, efforts often return to ‘busi-
ness as usual’ approaches in the aftermath of outbreaks, 
particularly if interventions are funded by external actors 
and if governance frameworks are not amended to 
facilitate long-term change.25 As this example suggests, 
it therefore remains to be seen whether stated commit-
ment to applying a One Health ethos will be sustained in 
the long-term or whether it will be set aside in favour of 
other approaches.1 30
Against this background of heightened political and 
financial interest in One Health and existing research 
that highlights differing perspectives on how to opera-
tionalise One Health,10 25 31 32 our study seeks to identify 
new opportunities and to examine longstanding barriers 
to sustaining political attention and realising systemic 
change.
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Table 1 Examples of One Health Networks identified through a systematic review,22 and a summary of the networks’ self-
reported activities
Network name Key activities
Connecting Organisations 
for Regional Disease 
Surveillance (CORDS)
CORDS is a non-governmental organisation comprised of six regional networks that operate 
across South East Europe, Southern and East Africa, South East Asia, The Mekong Basin 
and the Middle East. The collective action of these networks—detecting and responding to 
outbreaks at the community level—enables the organisation to ‘exchange information between 
surveillance systems globally’. CORDS applies a One Health approach to their surveillance and 
monitoring, data and information sharing and communication and collaboration activities, as 
well as capacity building.64
One Health Commission, 
One Health Platform, One 
Health Initiative
These organisations work collaboratively to operationalise the One Health approach by 
connecting One Health actors, creating strategic networks and partnerships, and raising 
awareness of the approach and key One Health issues. The One Health Commission mainly 
functions as a communication and collaboration platform, facilitating data and information 
exchange as well as advocating and building capacity in One Health.65
USAID Emerging Pandemic 
Threats 2 (EPT 2) 
Programme, Preparedness 
and Response (P&R) and 
One Health Workforce 
(OHW) Projects
Under the umbrella of the USAID EPT 2 Programme, the P&R Project is charged with 
establishing and strengthening National One Health Platforms across Africa and South East 
Asia. The Project focuses on activities pertaining to disease surveillance and monitoring, 
national-level capacity building, communication and collaboration and is responsible for 
disbursing funds to support One Health activities.66 67
Another branch of the EPT2 Programme, the OHW Project aims to transform the health 
workforce through two established university networks—the One Health Central and Eastern 
Africa (OHCEA) network and the South East Asia One Health University Network (SEAOHUN)—
and is mainly focused on capacity building activities.68
MeTHods
We conducted a mixed methods study between June 
2017 and June 2018, first qualitatively investigating views 
held by major policymakers and funders of One Health 
programmes about the factors impeding or supporting 
political attention and a shift from rhetoric (expressed 
commitment) to long-term systemic changes. We then 
triangulated these findings with quantitative data about 
the current strategic functioning—including scope of 
work, regions of focus and stakeholders engaged—of 
One Health Networks (OHNs).
Qualitative study
We focused our qualitative study on ‘elite policymakers’, 
which we defined as representatives from organisations 
that hold a degree of influence over the global One 
Health agenda owing to the organisations’ control of 
funding or of leadership in the development of guide-
lines and policies for One Health. Two pilot interviews, 
followed by two rounds of interviews, were conducted 
with 25 informants. A first set of informants were selected 
purposively by identifying a list of key organisations 
involved in One Health activities. These included the 
Tripartite organisations—the FAO, OIE and WHO—and 
major One Health funders, such as USAID and the World 
Bank. This was followed by snowball sampling based on 
recommendations from informants. During the snow-
balling process, efforts were made to identify represent-
atives across human, animal and environmental health 
disciplines and different sectors, such as academia and 
intergovernmental organisations, including dissenting 
voices. All elite policymakers identified were based in 
Europe or the USA.
We invited the most senior representative working on 
One Health issues from each organisation to participate 
in the interviews. Interview questions explored the rela-
tionship dynamics between the many actors working in 
the One Health policy space, the political context in 
which these actors operate, governance arrangements 
and views on the progress made towards operationalising 
One Health. Interviews were predominantly conducted 
by telephone or by Skype (two were conducted in person) 
in English and lasted between 30 and 75 min. Key infor-
mant affiliation types are detailed in table 2. After seeking 
informed consent, interviews were audio recorded and 
transcribed verbatim. No informants declined recording 
or transcription of their interview and it was agreed that 
organisational characteristics could be included when 
reporting results, along with verbatim quotes, but indi-
vidual’s personal details would remain anonymous. Tran-
scripts and research notes were managed and analysed in 
Dedoose.
The researchers followed guidance detailed by Fernald 
and Duclos on approaches for conducting qualitative 
analysis in teams.33 Following an initial round of induc-
tive analysis, codes and definitions were discussed by the 
research team and an initial set of primary codes was 
agreed on. Further inductive and deductive rounds of 
coding were then completed. Our analysis was guided 
by frameworks developed by Shiffman and colleagues on 
the determinants of political priority34 and on the emer-
gence and effectiveness of global health networks.35 We 
focused on three components presented in these frame-
works: actor power (the strength of the individuals and 
organisations operating in the One Health community), 
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Table 2 Key informants interviewed are coded by affiliation type, followed by their informant number and the region in which 
they are based, for example, informant number two is coded as ‘MG2EUR’
Affiliation type
Region
TotalEurope (EUR) USA
Organisation with multigovernment membership (MG) 2, 7, 13, 15, 18, 19 24 7
Single government organisation (G) 4 8, 9 3
Networking platform for One Health (N) 1, 3 6, 14 4
University or One Health research body (U) 5, 11, 20, 21, 25 10, 12, 16, 22 9
Private funding body (F) 23 1
For-profit company (FP) 17 1
Total 15 10 25
Source: Authors’ tabulation of informants’ data.
political context (the environment in which these actors 
operate) and issue characteristics (key features of the 
One Health approach).
Quantitative analysis of one Health networks (oHns)
We analysed quantitative data collected by the authors for 
a larger study on the strategic functioning of OHNs in 
order to triangulate findings from the qualitative analysis 
and to serve as a case study of actor networks operating 
in One Health.22 Briefly, Khan and colleagues defined an 
OHN as an engagement between two or more discrete 
organisations or government entities with at least two of 
the following sectors represented: animal health, human 
health and environment/ecosystem. Through a system-
atic search of numerous academic and grey literature 
sources, the group identified 100 OHNs and extracted 
information about their operations with respect to the 
networks’ geographical focus, engagement across human, 
animal and environment health sectors, key activities, 
stakeholder involvement and accountability structures 
using a standardised extraction template. This informa-
tion was used to analyse network characteristics and activ-
ities, specifically in relation to findings emerging from 
the qualitative study.
Presentation and feedback on findings
We validated our findings by sharing preliminary results 
of the quantitative and qualitative analyses with approx-
imately 50 international participants at the Prince 
Mahidol Award Conference during a special session on 
One Health (Bangkok, January 2018).
ethical approval
Ethical approval for the research was received from the 
London School of Hygiene & Tropical Medicine ethics 
committee.
resulTs
We first present the main findings from our qualitative 
analysis and, where relevant, show data from the case 
study of OHNs that could provide objective insights to 
triangulate views held by interviewees.
Power struggles between stakeholder groups impede the 
establishment of required systemic changes
From the perspective of all respondents, despite accept-
ance of the importance of a One Health approach by a 
wider group of policymakers and funders in recent years, 
One Health implementers have struggled to coalesce 
around an operational definition that will lead to tangible 
systemic changes to improve multisectoral collaboration:
‘What do we want to achieve in ten years or twenty years 
with this One Health concept? Okay, we want that the sec-
tors work together, better and so on, but what does it mean 
exactly? Working better, working together, what does it 
mean?’ (MG15EUR).
A lack of clarity on how to achieve synergistic working 
across the animal, human and environmental health 
sectors was perceived to stem from, and lead to, conflict 
between different stakeholder groups in the movement, 
hampering their capacity to act collectively (U20EUR; 
U12US; MG19EUR; U10US; U21EUR; F23EUR). Power 
relations appeared to be at the root of this problem, with 
all respondents commenting on an inequitable distribu-
tion of power in terms of decision-making and funding 
between the three sectors. However, which sector yielded 
the most power was contested. Some respondents 
(U5EUR; U10US; U12US; U16US; N14US; U20EUR; 
U21EUR) commented on the historic dominance of the 
veterinary sector, but noted this sector’s limited power 
compared with human health practitioners at present. 
One respondent summarised this sentiment: ‘…and 
[animal health stakeholders] don’t even know there’s 
a table to sit around because it’s run from the human 
side, by the humans, and the vets are told what to do’ 
(MG18EUR). All informants perceived human health 
practitioners to occupy a privileged position in the move-
ment, which some perceived as an impediment to collab-
oration (N14US; MG7EUR; MG18EUR; U16US; U10US). 
One interviewee additionally indicated that the increase 
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in political and financial attention to One Health is 
driving the human health sector to try and retain control:
‘I think there’s a fear of loss of control. Medical profes-
sionals tend to want to be…in charge of health. They don’t 
want to share their authority, and I think that continues to 
be a challenge’ (U10US).
It was felt that power differences between the human 
and animal health sectors may be rooted in a lack of 
respect for technical expertise of veterinary health actors 
among human health practitioners:
‘I think there is a historical, yeah, I’ll say it, lack of respect 
for the science coming out of the veterinary domain. They 
say, 'Oh, what do they do? They spend their time wonder-
ing about farms, they don’t know anything about science,' 
and I think that’s been a culture that we’ve had to battle…’ 
(MG18EUR).
Additionally, it was suggested that stakeholders trying 
to operationalise One Health lacked the essential skills 
and knowledge necessary for overcoming power struggles 
and introducing systemic changes to support interdisci-
plinary working (U12US; U25EUR), with concerns raised 
that members of the movement tend to have expertise 
in their respective fields but do not have a clear under-
standing of other members’ approaches, which impedes 
effective collaboration:
‘And the human health people really [need] to learn some 
basic veterinary things. And both of them need to learn 
some principles of environmental health. And we're not 
really pushing that…’ (U12US).
Several respondents noted the need to develop and 
expand on existing training and educational initiatives 
for One Health (at the secondary and tertiary level) so 
that the next cohort of leaders are better equipped to 
overcome organisational silos (N6US; MG7EUR; N14US; 
U21EUR; MG24US).
Although all respondents stressed the need to involve a 
diverse group of stakeholders (in terms of discipline and 
sector) in the movement, they also raised concern that 
such diversity can impede cohesion and foster disagree-
ment between stakeholders, as illustrated below:
‘…People come with their own ideas of what One Health is 
and they have their own expectations and their own agen-
das and bringing everybody together in one network and 
then having a common voice, I think that’s quite difficult’ 
(U20EUR).
Another respondent (NGO20EUR) explained that 
there are challenges to bringing diverse voices together 
and that this may explain why some stakeholders are 
less frequently represented in One Health collabora-
tions. Although interview respondents focused on the 
balance of power between human and animal health 
stakeholders, our quantitative analysis of stakeholders 
currently involved in OHNs revealed that it was actually 
the environmental health sector that was poorly repre-
sented in OHNs; 31% of OHNs analysed included human 
and animal health stakeholders without a representative 
from the environmental sector, whereas only 3% did not 
include an animal health stakeholder and 2% did not 
include a human health stakeholder. We also found that 
government bodies and academic institutions are repre-
sented in 78% and 76% of all networks, respectively. In 
contrast, private for-profit organisations were engaged in 
23% of OHNs and members of communities affected by 
OHN activities in 10% of collaborations.
Diverse views of informants indicated that the role of 
the for-profit private sector was particularly contentious. 
The majority of respondents noted minimal engagement 
of the private sector; however, perspectives on the best 
way forward were divided. Five respondents viewed the 
for-profit private sector as under-represented in the One 
Health community (MG18EUR; G8US; G4EUR; FP17US; 
U10US), and as such, argued that they should be further 
engaged to leverage their unique expertise. In contrast, 
three respondents argued that private sector actors 
should not have a role in One Health due to the exis-
tence of an innate conflict between public and private 
interests (MG18EUR; MG15EUR; U25EUR). Another 
three respondents took a more nuanced approach and 
argued that the private sector should only be engaged 
sometimes and under certain circumstances (MG2EUR; 
N3EUR; U20EUR) to avoid them becoming unduly influ-
ential. For example, it was proposed that while private 
sector actors should generally be consulted, they should 
not be involved in decision-making when they have a 
financial stake in the issue under discussion, stating that 
they: ‘…would not invite people who have a commercial 
interest to the table’ (MG2EUR).
Although our analysis of OHNs showed that 54% of 
collaborations involved a civil society or non-govern-
mental stakeholder, one participant argued that sustained 
action on furthering One Health will be impeded in part 
due to minimal engagement with civil society organi-
sations (U10US). They further argued that the move-
ment predominantly engages select ‘technocrats’ and 
that increased involvement of civil society ‘…[can] ulti-
mately drive One Health to be more widely engaged…’ 
(U10US).
lack of agreement on leadership and governance structures 
is a core issue
Respondents identified weak guiding institutions as a 
critical challenge to operationalising the One Health 
approach. It was generally agreed that, at present, the 
Tripartite Agreement of the FAO-OIE-WHO was the ‘…
centre of gravity…’ (G8US) for the movement, and as 
such, was well placed to assume a leadership role at the 
global level; however, views on the effectiveness of this part-
nership varied. Some respondents depicted the Tripartite 
as a key enabler. For example, one informant commented 
on its capacity to set a model for country-level networks: 
‘The ability of the Tripartite to…come together, help 
identify clear strategic priorities, we see as a big enabler 
and that’s what we encourage at the national level as 
well’ (MG13EUR). In contrast, others voiced concerns 
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regarding the Tripartite’s capacity to effectively collabo-
rate and lead. A respondent with significant experience 
working in partnership with the FAO, OIE and WHO, 
reflected on the challenges associated with bringing 
together the distinct organisational cultures, priorities, 
approaches and interests of the Tripartite’s members: 
‘You’d have better luck with a shotgun marriage…there 
are such cultural divides between those three organisa-
tions…so they’re having a hard time’ (G8US).
Some respondents’ perceptions also oscillated between 
the normative and political benefits of the Tripartite, and 
its practical contributions: ‘They haven’t done so much 
yet…I think they endorse the concept but I think in terms 
of practical implementation and change, not so much is 
happening’ (U20EUR).
More than half of all respondents commented on the 
need to develop guidelines and core values or competen-
cies shared across One Health stakeholders in order to 
operationalise One Health. However, a few respondents 
did not agree that standardisation and centralised coor-
dination was the best way forward:
‘I’m sure collectively the effort will do a lot of good and it’s 
perhaps not entirely realistic to think that [One Health] 
should have a nice, tidy governance structure that we can 
all understand and that’s coherent. I see it as inevitably 
messy’ (MG13EUR).
It was further argued by one interviewee that central-
ised governance arrangements and the standardisation 
of approaches may in fact impede One Health operation-
alisation by stifling adaptability in the field, cautioning 
against ‘…One Health becoming a straightjacket’ and 
playing ‘…the game of power around leadership and 
imposing things…because it’s probably not what we 
need with One Health’ (MG24US). Despite differences 
in views about One Health governance, there was broad 
agreement about the need for better coordination across 
OHNs.
Attention to antimicrobial resistance (AMr) presents 
opportunities and challenges for advancing a broad one 
Health approach
Respondents identified increased national-level and glob-
al-level attention to AMR as a critical opportunity for One 
Health approaches to be prioritised (N3EUR; U5EUR; 
U16US; MG18EUR; U22US; F23EUR). Concerns were 
expressed that One Health may not be able to maintain 
traction during ‘peacetime’ if the approach only gains 
attention during outbreaks: ‘We’re all dancing around Big 
Bang, and pandemics, and the next Ebola’ (MG24US). 
Contrasting AMR to Ebola in terms of harnessing polit-
ical attention, it was noted that AMR is a global phenom-
enon that will remain a salient concern in the long term:
‘…the issue of emerging pandemic threats is certainly one 
that galvanises people around One Health… but not every 
country is subject to the threat of Ebola… On the other 
hand, just about everybody in the world today is suffering 
or going to suffer from the effects of AMR…If I were to 
recommend where the future of One Health activities and 
resources ought to be applied, I would say it’s in AMR’ 
(FP17US).
Some respondents (U16US; MG18EUR) also noted 
that AMR provides an opportunity to overcome sectoral 
silos and to generate greater cohesion among concerned 
actors, which, as discussed earlier, has been challenging 
thus far.
Despite widespread acknowledgement of the opportu-
nities AMR presents for further operationalisation of One 
Health, our quantitative analysis suggests that AMR was 
not a significant focus area for OHN activities as stated 
on websites or publicly available documents. While the 
majority (67%) of OHNs focused on addressing commu-
nicable diseases, only five of these networks stated that 
they work on AMR. Overall, 32% of networks did not 
work on any specific disease area and instead stated that 
their activities covered systems strengthening functions, 
such as capacity building or communication broadly.
Absence of an evidence base to justify future investments 
in one Health may result in dwindling political and financial 
support
Several informants (N3EUR; U12US; U20EUR; U21EUR; 
U22US) noted exceptional challenges in developing 
credible indicators to assess the impact of applying a One 
Health approach, which may result in limited evidence 
about the results of ongoing investments and activities. In 
line with this sentiment, the quantitative case study found 
that while 74% of OHNs clearly defined their mission, 
vision or objective, only half of all networks stated their 
projected outputs or goals, and only 15% referred to 
a monitoring and evaluation (M&E) strategy on their 
website. This low reporting of specific M&E plans or indi-
cators of success may reflect the challenge described by 
interviewees of standardising One Health operations and 
impact assessment.
There were conflicting views on whether there should 
be standardised indicators to assess severity of diseases 
and impact of a One Health approach. The complexity 
of One Health interventions was discussed frequently 
(N6US; U12US; FP17US; MG18EUR; F23EUR) with 
one respondent noting: ‘…There are so many dimen-
sions to it that it makes your head spin’ (F23EUR). A 
named effort to improve standardisation of outcome 
reporting in order to improve the evidence base for One 
Health was the Checklist for One Health Epidemiolog-
ical Reporting of Evidence (COHERE).12 One respon-
dent advised learning from best practice in regions that 
were perceived to be more advanced in operationalizing 
One Health, such as East Asia, ‘…to avoid reinventing 
the wheel…’ (MG18EUR). However, several respondents 
commented that One Health approaches are likely to be 
highly context specific (G8US; G9US; U16US; FP17US; 
U22US).
Four informants (N3EUR; N6US; MG15EUR; U22US) 
spoke of the absence of a robust evidence base to 
demonstrate the added value of applying a One Health 
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Figure 1 Vicious cycle impeding a shift from expressed 
political commitment to long-term systemic changes for 
operationalising One Health.
approach, with concern expressed that difficulties in 
providing evidence of impact from investments in One 
Health may hamper sustainability:
‘I think many networks have been created when One 
Health was trendy…but at the end they have not been very 
sustainable because what was missing is really what is the 
added value of this network’ (MG15EUR).
dIsCussIon
Our investigation of evolutions in the One Health move-
ment following a recent surge in political and financial 
attention identified new and longstanding challenges 
to enhanced collaboration. Attention to One Health at 
high-level political fora appears to have only increased 
power struggles around who ‘owns’ the One Health move-
ment, particularly between dominant human and animal 
health stakeholders. A key point highlighted is that 
stakeholders driving the movement had not substantially 
developed their collaboration-building skills and often 
lacked the respect or awareness for disciplines other than 
their own. As indicated by our qualitative and quantita-
tive data, the injection of funding to support One Health 
activities has been accompanied by a rise in organisations 
working in this area; however, we found that this has also 
lead to difficulties in coordination of various fractions,10 
with notable gaps in representation of certain groups, 
such as civil society organisations. Finally, even though 
the Tripartite collaboration has made progress through 
the development of working agreements and guidelines, 
the majority of interviewees felt strongly that more was 
needed in terms of guidance on implementation and to 
facilitate coordination of activities. Our analysis suggests 
that the absence of clearer guidelines for organisations 
implementing One Health activities may be related to 
the weak evidence base to identify areas to prioritise for 
continued investment.
These findings build on a growing literature of One 
Health policy analysis,10 18 25 31 32 particularly on the issue 
of the lack of involvement of civil society organisations 
in the One Health movement and on power struggles 
within the community.10 18 As mentioned in the introduc-
tion, One Health gained its prominence following the 
increasing interaction between the FAO, OIE and WHO 
in response to the avian influenza outbreak in the early 
2000s.18 In contrast to other global health initiatives, One 
Health was driven by these international organisations 
whereas the role of civil society organisations and affected 
communities has been largely neglected.10 At the centre 
of the AIDS movement, for example, were the communi-
ties affected by HIV and they were critical for generating 
attention and resources to sustain a long-term response, 
such as the establishment of the Global Fund to Fight 
AIDS, Tuberculosis and Malaria and bringing a health 
issue to the UN Security Council.36 37 As this example 
suggests, linking with civil society groups working on 
issues relevant to One Health is important for generating 
widespread political support for the movement rather 
than remaining confined to select organisations and a 
distinct global policy community.34
The institutions with the greatest hand in guiding and 
governing the One Health movement (FAO, OIE, WHO) 
were described by many interviewees to have adopted an 
undefined and unrealistic vision of One Health that has 
allowed for subgroups and stakeholders to shift opera-
tionalisation in directions most aligned to maintaining 
their own interests and influence in the movement, as 
illustrated in figure 1.18 This ‘functional adoption’ of One 
Health enables dominant subgroups or sectors within 
the movement to shape narrative, knowledge, policy 
responses and allocation of financial resources to issues 
they are mandated to address or that that they perceive 
as important by increasing ambiguity and diluting the 
meaning and evidence for the approach.10 18 25 31 Strong 
governance and leadership is of particular importance 
for building a shared vision and for defining agreed and 
actionable strategic priorities; in lieu of this, subgroups 
within a movement may compete over which issues 
should take priority. Growing momentum around Plan-
etary Health, for example, may reflect the differences in 
vision for specific areas of work to be prioritised between 
One Health stakeholders and others who also want to 
increase collaboration between human, animal and envi-
ronmental health stakeholders.38 39
Our results also resonate with findings described else-
where in the literature on the challenges facing global 
health movements.34 40 41 Indeed, the global health 
field has witnessed the rise, short-term persistence and 
decline of several movements34 35 42 recognition of which 
has led researchers to investigate the determinants of 
political priority for global health movements.34 35 41–45 
Through this research, the governance of global health 
movements—establishing informal and formal institu-
tions to facilitate collective action40—appears to emerge 
as a particularly important determinant of sustained 
attention to global health issues, where cohesive gover-
nance arrangements have contributed to the success 
of networks addressing some issues (such as tobacco 
control46 and maternal mortality44), whereas fragmented 
governance has impeded progress for others (such as 
alcohol harm47 and early childhood development48). The 
Scaling Up Nutrition initiative is an example where chal-
lenges existed in converting global commitments—such 
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box 2 specific recommendations to further one Health 
operationalisation emerging from this study
1. Capitalise on the ‘policy window’ afforded by recent global attention 
to AMR in order to galvanise support for the broader implementation 
of the One Health approach over the long-term and across various 
contexts.
2. Encourage civil society mobilisation and inclusion in decision-mak-
ing around One Health to build stronger links between policymak-
ers, funders and communities implementing and affected by One 
Health programmes on the ground.
3. Expand current joint education programmes for human, animal and 
environmental health specialists at earlier career stages, including 
training in technical, leadership and partnership skills.
4. Improve monitoring and evaluation of the numerous One Health ini-
tiatives to strengthen the evidence base on the effectiveness of One 
Health approaches, the economic benefits of their application and 
best practices in the field. Promote wider uptake of tools to stand-
ardise monitoring and reporting.
5. Investigate the most appropriate approaches for guiding the im-
plementation of One Health at the global, regional, national and 
subnational level. In the meantime, immediate action can be taken 
to facilitate coordination of One Health activities, for example, by 
maintaining a global database.
as the UN Decade of Action on Nutrition—into coherent 
action on the ground, where narrow coalition-building 
across different sectors, internal conflict between stake-
holders, a lacking or inconsistent evidence base and frag-
mented governance arrangements have been outlined as 
key barriers to achieving results.41 49 This is also illustrated 
by the primary healthcare movement, where momentum 
slowed as the vision offered by leaders was deemed unre-
alistic and ultimately subgroups splintered determined 
by their own interests, priorities and desire to demon-
strate measurable impact.50
In addition to highlighting some new challenges, we 
also identified a policy window—the current high-level 
commitments to combat the ‘global crisis’ of AMR51–53—
as a potentially important opportunity to advance 
changes to structures and institutions such that collab-
orative working according to One Health principles is 
better supported. AMR was perceived to generate the 
required sense of urgency for action in the way that the 
West African Ebola epidemic and other outbreaks have 
in recent years. Owing to the wider geographic and 
longer-term impact of AMR (as compared with other 
emerging infectious diseases that affect a smaller group 
of countries), it was identified as a uniquely powerful 
platform to enable sustained commitment and action 
on One Health going forward. Indeed, many of the 
high-level political statements in support of the One 
Health approach have been released in the context of 
addressing AMR.53–56 Nevertheless, it remains to be seen 
how well global attention to AMR is capitalised to further 
operationalise One Health; we found that the majority 
of OHNs do not appear to focus on AMR yet despite 
action on communicable diseases dominating their activ-
ities, perhaps because other health issues are considered 
more pressing in the local contexts where these networks 
work. Interviewees felt that using the window of oppor-
tunity afforded by AMR to operationalise One Health 
may produce political support and generate measur-
able progress on tangible outcomes as, for example, 
was seen with other issue-specific initiatives, such as the 
Global Fund to Fight AIDS, Tuberculosis and Malaria.42 57 
However, using this policy window also runs the risk of 
skewing countries’ activities towards a health issue that 
may not be a domestic priority and precipitating more 
disease-specific or ‘vertical’ programmes, especially since 
current One Health operationalisation remains largely 
focused on specific health issues, such as pandemic influ-
enza preparedness.1 We see this tension occurring with 
another initiative that has become a buzzword among 
global health actors—‘Health Systems Strengthening’ 
(HSS). A number of programmes claim to be HSS while 
focusing on disease-specific interventions, which risks 
undermining the movement’s goal of inclusive and effec-
tive health systems.58
We summarise specific recommendations for sustaining 
political commitment to One Health, based on views of 
our interviewees, in box 2. These include increasing civil 
society engagement in One Health and building links 
between grassroots organisations, policymakers and 
funders. With the current political attention to AMR, 
rapid engagement of civil society groups to draw atten-
tion to locally relevant health issues may help sustain 
momentum to encourage longer-term investments in 
operationalising One Health. Interviewees also proposed 
more joint training schemes for human, animal, and 
environmental health specialists at earlier career stages 
in order to build an understanding of and respect for 
the other disciplines.59 60 A further critical recommenda-
tion for translating the stated political support for One 
Health into sustained action with measurable impact is 
to draw on the work of other disciplines, for example, 
in the social sciences, to develop standardised indicators 
and monitoring systems to strengthen the One Health 
evidence base. This will help to assess the comparative 
effectiveness of applying a One Health approach, the 
economic benefits of its application and to identify best 
practices in the field.2 12 29 60–63
While our analysis indicated potential solutions to 
several of the challenges identified for implementing 
One Health approaches, we did not identify straightfor-
ward strategies to tackle serious impediments related to 
power struggles between human, animal and environ-
mental health sectors and the lack of an agreed lead-
ership or governance structure. While clear and strong 
governance structures have been found to be important 
for sustaining political commitment for diverse global 
health movements,45 48 wider agreement about overar-
ching governance arrangements (currently lacking for 
One Health) is an essential first step. In the case of One 
Health, we found polarised views about the need for a 
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centralised structure for strategic coordination and 
leadership.
Our study is not without limitations that should be 
considered when interpreting our results. We attempted 
to collect information about the sector (human, animal or 
environment) that study participants most closely identi-
fied with, in order to understand potential biases in their 
perspectives, but found that several felt most comfortable 
labelling themselves as ‘One Health’. We were therefore 
unable to consider whether the primary training or sector 
of interviewees was relevant in shaping their views. As we 
focused our qualitative study on key informants based in 
influential funding and policymaking organisations oper-
ating at the global level (who we found to be based in 
Europe and the USA), we acknowledge that the analysis 
does not represent views from low-income and middle-in-
come countries. In particular, future studies could focus 
on East Asia as this region was mentioned as being ahead 
in operationalising the One Health approach. However, 
we successfully engaged all senior policymakers and 
funders that we aimed to interview in line with our study 
scope and reached a high degree of consistency with 
our findings. We also validated our findings by sharing 
some preliminary results with a subset of informants and 
receiving feedback.
ConClusIon
Since 2010, political and financial attention to One 
Health has surged, and One Health has been framed 
by the Tripartite to have a broader scope. These devel-
opments have been accompanied by an increase in the 
number of organisations conducting diverse activities 
under the One Health umbrella and by heightened 
power struggles around which stakeholders have the 
authority to define One Health. Owing to a perceived lack 
of guidance on priority focus areas and on how best to 
operationalise One Health, concerns were expressed that 
stakeholders are pulling operationalisation in directions 
most aligned to their own interests, thereby splintering 
the movement and stifling progress on systemic change. 
While the international attention to AMR is highlighting 
the need for investment in a One Heath approach, there 
is a risk that One Health initiatives will remain focused 
on disease-specific issues and that structural changes to 
sustain collaboration between sectors will be neglected. 
Several opportunities were identified to capitalise on the 
current growth in One Health initiatives and funding. 
Better monitoring and evaluation of the numerous 
ongoing activities is needed to strengthen the evidence 
base to support future funding and allow development 
of more precise guidelines on best practices. Further, to 
bridge divides between stakeholders, capacity building 
activities should additionally focus on collaboration skills 
and joint training of human, animal and environmental 
health specialists.
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